Who invested in Axial Biotherapeutics?
Axial Biotherapeutics's investors include Domain Associates, Longwood Fund, Heritage Medical Systems and Seventure Partners/ Longwood Fund.
United States · Series B startup
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$54Mraised across 3 rounds since 2016, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by FinSMEsSEC filing: $5.0M sold, first sale Jun 2019
Reported by FinSMEsSEC filing: $20M sold, first sale Nov 2018
Reported by FinSMEsSEC filing: $9.6M sold, first sale Nov 2016
From the SEC filings it signed: 2 on the team.
On the board, as filediEric C. De La FortelleHenry C. WolfJames C. BlairRichard P. AldrichRonald C. RenaudSakae C. AsanumaSarkis K. MazmanianScott C. Brun
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Axial Biotherapeutics's investors include Domain Associates, Longwood Fund, Heritage Medical Systems and Seventure Partners/ Longwood Fund.
Axial Biotherapeutics has raised $54M across 3 rounds since 2016.
Axial Biotherapeutics's most recent round was a Series B of $10M in Jun 2019.
Axial Biotherapeutics's largest round on record is $25M (Series B), in Feb 2019.
Axial Biotherapeutics's first round on record, in Dec 2016, was backed by Domain Associates and Longwood Fund.
Axial Biotherapeutics's latest named round is a Series B, in Jun 2019.
Axial Biotherapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.